| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_29800004a1adc1fb9b840e645d147be5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-746
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1816
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate |
2017-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b978478cdc24b7e004b430d02141f57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5e35083efbb140d75a30883812ebc0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64662160e4b620670e652070acf73b39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e4a46d76941afb83b02e1876a556f4c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d2cf03c31b410092cf2a4a3cae63773
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbf1030de27091a8c910673f192f16fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d36dd0e8f7b1fbf4d655be721c36e83e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c999bab8c0e6dcca47dd7b3c4b313fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08cfa7031f7d83caba4b20b83f349bf2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11f17b4323d29de09a03b26f150a8d54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46c402e9121677ef5362a895c3a2f7be |
| publicationDate |
2018-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201808326-A |
| titleOfInvention |
Use of basic recombinant human erythropoietin for treating patients with spinal cord cerebral dysfunction with CAG repeat mutation |
| abstract |
The present invention relates to the use of a basic recombinant human erythropoietin (rhEPO) as an active ingredient and a pharmaceutical composition administered nasally for the treatment of spinal cerebellar dysfunction with CAG repeat mutation Type 2) Patient's use. Another object of the present invention is to divide patients into a stratified method for responders and non-responders to treatment with basic rhEPO. |
| priorityDate |
2016-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |